ACR Meeting Abstracts

ACR Meeting Abstracts

Abstracts tagged "therapy and tocilizumab"

  • Abstract Number: 2754 • ACR/ARHP Annual Meeting 2018

    Comparison between Tocilizumab Prescribed As Monotherapy Versus Combined with Conventional Immunosuppressant Agents in Giant Cell Arteritis Patients

    Monica Calderón Goercke1, Diana Prieto Peña1, Javier Loricera2, Vicente Aldasoro3, Santos Castañeda4, Ignacio Villa-Blanco5, Alicia Humbría4, Clara Moriano Morales6, Susana Romero-Yuste7, Francisco Javier Narváez8, Catalina Gómez-Arango9, Eva Perez Pampín10, Rafael Melero11, Elena Becerra-Fernández12, Marcelino Revenga Martínez13, Noelia Álvarez-Rivas14, Carlos Galisteo15, Francisca Sivera16, Alejandro Olivé-Marqués17, Maria Concepcion Alvarez de Buergo18, Luisa Marena Rojas Vargas19, Carlos Fernandez-Lopez20, Francisco Navarro21, Enrique Raya Álvarez22, Eva Galindez-Agirregoikoa23, Beatriz Arca24, Roser Solans25, Arantxa Conesa26, Cristina Hidalgo-Calleja27, Carlos Vázquez28, Pau Lluch29, Jose Andrés Román Ivorra30, Sara Manrique-Arija31, Paloma Vela32, Eugenio De Miguel33, Carmen Torres-Martín34, Juan Carlos Nieto35, Carmen Ordas-Calvo36, Eva Salgado-Pérez37, Cristina Luna Gómez38, Francisco J. Toyos Sáenz de Miera39, Nagore Fernandez-Llanio Cornella40, Antonio García41, Carmen Larena42, Belén Atienza-Mateo43, José Luis Martín-Varillas43, Natalia Palmou-Fontana43, Vanesa Calvo-Río43, Carmen González-Vela44, Alfonso Corrales43, María Varela-García45, Elena Aurrecoechea46, Raquel Dos Santos47, Angel García-Manzanares12, Norberto Ortego Centeno48, Sabela Fernández49, Francisco Ortiz-Sanjuán50, Montserrat Corteguera34, Miguel Angel González-Gay43, José Luis Hernández2 and Ricardo Blanco43, 1Rheumatology, Rheumatology. Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, 2Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, 3Hospital Alto Deba. Mondragón. Spain, Mondragon, Spain, 4Rheumatology, Hospital La Princesa. Madrid. Spain, Madrid, Spain, 5Hospital de Sierrallana. Torrelavega. Spain, Torrelavega, Spain, 6Rheumatology, Complejo Asistencial Universitario de León. León. Spain, León, Spain, 7Hospital de Pontevedra. Spain, Pontevedra, Spain, 8Rheumatology Department, Hospital de Bellvitge. Barcelona. Spain, L’Hospitalet de Llobregat, Spain, 9Hospital Alto Deba, Mondragón. Spain, Mondragón, Spain, 10Rheumatology Division. Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain, 11Rheumatology, Complexo Hospitalario Universitario de Vigo, Vigo. Spain, Vigo, Spain, 12Hospital Universitario de Torrevieja, Alicante. Spain, Alicante, Spain, 13Hospital Universitario Ramón y Cajal. Madrid. Spain, Madrid, Spain, 14Hospital Universitario Lucus Augusti, Lugo. Spain, Lugo, Spain, 15Rheumatology, Hospital Parc-Taulí, Sabadell, Spain, 16Rheumatology, Hospital General Universitario de Elda. Comunidad Valenciana. Spain, Elda, Spain, 17Rheumatology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 18Rheumatology, Hospital Río Carrión. Palencia. Spain, Palencia, Spain, 19Rheumatology Department, Hospital General La Mancha Centro, Alcázar de San Juan, Spain, 20Servicio de Reumatología, Complexo Hospitalario Universitario de A Coruña (CHUAC), A Coruña. España, A Coruña, Spain, 21Hospital General Universitario de Elche, Alicante. Spain, Alicante, Spain, 22Rheumatology, Hospital Universitario San Cecilio. Granada. Spain, Granada, Spain, 23Rheumatology, University Hospital of Basurto, Bilbao, Spain, 24Hospital Universitario San Agustín, Avilés. Spain, Avilés, Spain, 25Autoimmune Systemic Diseases Unit, Department of Internal Medicine, Hospital Vall d'Hebron, Autonomous University of Barcelona, Spain, Barcelona, Spain, 26Rheumatology, Hospital Clínico Universitario de Valencia. Spain, Valencia, Spain, 27Rheumatology, Hospital Clínico Universitario de Salamanca, Salamanca. Spain, Salamanca, Spain, 28Hospital Miguel Servet, Zaragoza. Spain, Zaragoza, Spain, 29Rheumatology, Hospital Mateu Orfila. Menorca. Spain, Menorca, Spain, 30Hospital La Fe. Valencia. Spain, Valencia, Spain, 31Medicine, University of Málaga, MÁLAGA, Spain, 32Reumatología, Hospital General Universitario Alicante, Alicante, Spain, 33Rheumatology, University Hospital La Paz, IdiPaz, Madrid, Spain, 34Complejo Asistencial de Ávila, Ávila. Spain, Ávila, Spain, 35Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain, 36Hospital Cabueñes, Gijón. Spain, Gijón, Spain, 37Rheumatology, Complejo Hospitalario Universitario de Ourense, Ourense. Spain, Ourense, Spain, 38Rheumatology, University Hospital Ntra. Sra. de La Candelaria, Santa Cruz de Tenerife, Spain, 39Hospital Virgen de La Macarena. Sevilla. Spain, Sevilla, Spain, 40Rheumatology Section. Hospital Arnau de Vilanova, Valencia, Spain, 41Hospital Unviersitario Virgen de las Nieves, Granada. Spain, Granada, Spain, 42Hospital General Universitario Gregorio Marañón, Madrid, Spain, 43Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, 44Pathology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, 45Complejo Hospitalario de Navarra, Navarra, Spain, 46Rheumatology, Hospital de Sierrallana. Torrelavega. Spain, Torrelavega, Spain, 47Complejo Hospitalario Universitario de Santiago. Spain, Santiago de Compostela, Spain, 48Medicine Department, Hospital Universitario San Cecilio. Granada. Spain, Granada, Spain, 49Rheumatology, Hospital Universitario San Agustín, Avilés. Spain, Avilés, Spain, 50Rheumatology, Hospital La Fe. Valencia. Spain, Valencia, Spain

    Background/Purpose: Giant cell arteritis (GCA) can be refractory to corticosteroid therapy (1-3). Tocilizumab (TCZ) has been approved in the treatment of GCA. There are no…

  • Abstract Number: 1436 • ACR/ARHP Annual Meeting 2017

    Therapeutic Drug Monitoring on Rheumatoid Arthritis Patients with Reduced Doses of Intravenous Tocilizumab

    Virginia Ruiz-Esquide1, Carla Bastida2, Mariona Pascal3, Jordi Yagüe3, Dolors Soy2 and Raimon Sanmartí1, 1Rheumatology Service, Hospital Clínic de Barcelona, Barcelona, Spain, 2Pharmacy Service, Hospital Clínic de Barcelona, Barcelona, Spain, 3Immunology Service, Hospital Clínic de Barcelona, b, Spain

    Background/Purpose: Tocilizumab (TCZ) is an effective treatment for rheumatoid arthritis (RA). There is great variability in intravenous (iv) TCZ serum concentrations among individuals. Moreover, initial…

  • Abstract Number: 977 • ACR/ARHP Annual Meeting 2016

    Tocilizumab As an Add-on Therapy to Glucocorticoids during the First 3 Months of Treatment of Giant Cell Arteritis: Results of a French Multicenter Prospective Open-Label Study

    Maxime Samson1, Hervé Devilliers2, Kim Heang Ly3, Francois Maurier4, Boris Bienvenu5, Benjamin Terrier6, Pierre Charles7, Jean-François Besancenot2, Anne-Laure Fauchais8, Christine Binquet9, Sylvain Audia10 and Bernard Bonnotte1, 1Department of Internal Medicine and Clinical Immunology, Hôpital François Mitterrand, CHU de Dijon, Dijon, France, 2Department of Internal Medicine and Systemic Diseases, Hôpital François Mitterrand, CHU de Dijon, Dijon, France, 3Internal Medicine, University Hospital of Limoges, Limoges, France, 4Department of Internal Medicine, HP Metz Belle Isle Hospital, Metz, France, 5Caen University Hospital, Caen, France, 6Internal Medicine, Cochin University Hospital, Paris, France, 7Department of Internal Medicine, Institut Mutualiste Montsouris, Paris, France, 8Department of Internal Medicine, CHU de Limoges, Limoges, France, 9INSERM, CIC 1432, Clinical Epidemiology Unit, Hôpital François Mitterrand, CHU de Dijon, Dijon, France, 10Department of Internal Medicine and Clinical Immunology, Hôpital François Mitterrand, CHU de Dijon; INSERM, UMR1098, University of Bourgogne Franche-Comté, FHU INCREASE, Dijon, France

    Background/Purpose:  Giant cell arteritis (GCA) is a large-vessel vasculitis usually treated with glucocorticoids (GC). GC are effective but responsible for substantial morbidity and mortality. Tocilizumab…

  • Abstract Number: 2383 • ACR/ARHP Annual Meeting 2013

    A Useful Mathematical Model Able To Predict The Early Response To Tocilizumab In Rheumatoid Arthritis

    Chiara Stagnaro1, Claudia Ferrari2, Rosaria Talarico3, Camillo Giacomelli1, Stefano Bombardieri1 and Laura Bazzichi1, 1University of Pisa, Rheumatology Unit, Pisa, Italy, 2Rheumatology Unit, University of Pisa, Pisa, Italy, 3Rheumatology Unit, Pisa, Italy

    Background/Purpose: In the last few year the introduction of biological agents has radically changed  the clinical outcome of patients with Rheumatoid Arthritis (RA). However, no…